Our Story

Our story began with one simple question: what would the world be like if most new medical device technology wasn’t stuck in regulatory limbo? In 2014, RegDesk Founder and CEO Priya Paul sought to answer that question.

Priya envisioned a single software platform that consolidates every step of the regulatory approval process, from initial intelligence gathering to application building and beyond.

From the start, the ambitious project attracted support from industry experts. DreamIt Health Philadelphia saw promise in the platform and provided funding to get the project off the ground in 2015. Since then, RegDesk has helped companies big and small get their devices to market faster and stay on the market longer.

RegDesk is a certified Minority Business Enterprise (MBE) with the National Minority Supplier
Development Council (NMSDC).

We are aligned with medical device companies in their mission to expedite access to medical and diagnostic products to patients worldwide. Our AI-enabled regulatory compliance platform is an attestation to that commitment.

– Priya Paul
Founder & CEO, RegDesk

OUR VALUES

Valuable Impact

Customer Obsession

Constant Innovation

Ethical Collaboration

OUR LEADERSHIP

Jixian Wang

CTO

Priya Paul

Founder & CEO

Dan Piscatelli

CFO

RegDesk Regulatory Roundup

Never miss a thing in the world of medical device regulatory compliance. The latest regulatory news and updates are always on our feed.

A Guide to Navigating Regulatory Compliance for Medical Devices

by | Jun 14, 2024 | Medical Device Regulation Resources | 0 Comments

Worldwide, medical devices are subject to strict regulations, and for good reason — they are crucial for helping health care professionals identify, treat and combat...

Medical Device Regulations in the United States

by | Jun 14, 2024 | United States,USA | 0 Comments

Medical devices are highly regulated in the United States. Since U.S. regulatory compliance for MedTech is stringent and continuously changing, staying up-to-date on...

Leveraging RIMS for Global Market Access

Leveraging RIMS Platforms for Global Market Access

by | May 29, 2024 | HSA | 0 Comments

Global market access is crucial for medical device companies looking to reach new customers, enhance brand recognition worldwide and ultimately increase revenue...

EU Q&A on interruption or discontinuation of supply (specific aspects)

EU Q&A on Information Obligations Associated with Interruption or Discontinuation of Supply: Specific Aspects

by | Nov 19, 2024 | European Commission,European Union | 0 Comments

The new article describes in detail certain specific aspects to be taken into consideration by the parties involved in order to ensure the important information is duly communicated in accordance with the relevant regulatory requirements.

MHRA on future regulations (overview)

MHRA Guidance on Future Regulations: Overview

by | Nov 19, 2024 | Great Britain,MHRA,UK,United Kingdom | 0 Comments

The article describes in detail the approach the UK authority intends to apply when implementing amendments to the existing legal framework.

MHRA on future regulations (specific aspects)

MHRA Guidance on Future Regulations: Specific Aspects

by | Nov 19, 2024 | Great Britain,MHRA,UK,United Kingdom | 0 Comments

The new article provides additional clarifications regarding the upcoming changes to the UK regulatory framework.

TMDA on Good Review Practices (overview)

TMDA Guidelines on Good Review Practices: Overview

by | Nov 19, 2024 | Tanzania,TMDA | 0 Comments

The article outlines the key points of the regulatory approach applied in Tanzania when it comes to medical devices intended to be marketed and used in the country.

TMDA on Good Review Practices (implementation)

TMDA Guidelines on Good Review Practices: Implementation

by | Nov 19, 2024 | Tanzania,TMDA | 0 Comments

The new article explains in detail the way the relevant principles and practices should be implemented in order to ensure the safety and proper performance of medical devices allowed for marketing and use in the country.

TMDA on Good Review Practices (MD regulation)

TMDA Guidelines on Good Review Practices: MD Regulation

by | Nov 19, 2024 | Tanzania,TMDA | 0 Comments

The new article provides additional details and extensive clarifications regarding the approach to the regulation of medical devices and diagnostic products.

EU Q&A on interruption or discontinuation of supply (manufacturers' obligations)

EU Q&A on Information Obligations Associated with Interruption or Discontinuation of Supply: Manufacturers’ Obligations

by | Nov 18, 2024 | European Commission,European Union | 0 Comments

The new article provides additional clarifications regarding the specific scope of information-related obligations medical device manufacturers should comply with.

EU Q&A on Information Obligations Associated with Interruption or Discontinuation of Supply

by | Nov 18, 2024 | European Commission,European Union | 0 Comments

The article highlights the key points related to the manufacturers’ obligations in case of product supply being interrupted or discontinued.

SFDA on innovative devices

SFDA Guidance on Innovative Medical Devices: Overview

by | Nov 18, 2024 | Saudi Arabia,SFDA | 0 Comments

The article outlines the basics of the regulatory framework for innovative medical devices.